Retinoic acid receptors inhibit chondrogenesis, but their ability to block the cartilaginous scaffold of heterotopic endochondral ossification has not been explored. A study in mice shows that agonists of retinoic acid receptor-γ potently inhibit heterotopic endochondral ossification, suggesting therapeutic potential in people with this condition (pages 454–460).
References
Pignolo, R.J. et al. Clin. Rev. Bone Miner. Metab. 3, 261–266 (2005).
Shore, E.M. et al. Nat. Genet. 38, 525–527 (2006); erratum 39, 276 (2007).
Kaplan, F.S. et al. Cytokine Growth Factor Rev. 20, 399–407 (2009).
Shore, E.M. & Kaplan, F.S. Nat. Rev. Rheumatol. 6, 518–527 (2010).
Mohler, E.R. III et al. Circulation 103, 1522–1528 (2001).
Medici, D. et al. Nat. Med. 16, 1400–1406 (2010).
Hong, C.C. et al. Cytokine Growth Factor Rev. 20, 409–418 (2009).
Shimono, K. et al. Nat. Med. 17, 454–460 (2011)
Zasloff, M.A. et al. Clin. Orthop. Relat. Res. 346, 121–129 (1998).
Hoffman, L.M. et al. J. Cell Biol. 174, 101–113 (2006).
Sheng, N. et al. Proc. Natl. Acad. Sci. USA 107, 18886–18891 (2010).
Kennedy, K.A.M. et al. BMC Biol. 7, 67 (2009).
Yasuhara, R. et al. J. Biol. Chem. 285, 317–327 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kaplan, F., Shore, E. Derailing heterotopic ossification and RARing to go. Nat Med 17, 420–421 (2011). https://doi.org/10.1038/nm0411-420
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0411-420
- Springer Nature America, Inc.